Show simple item record

dc.contributor.authorDesouky, Elsayed
dc.description.abstractPurpose: To search for evidence base for using BCG in the fight against COVID-19 and the possible impact of these clinical trials on urology practice. Methods: A literature review about the basis of the ongoing clinical trials using BCG against COVID-19, as well as the use of BCG in urology and if there are any implications of these trials on our practice. Results: Based on data from some epidemiological studies, there are some current clinical trials on the use BCG as a possible prophylactic vaccine against SARS CoV-2 which can affect urology practice. Urologists are already struggling with the global shortage of BCG which can be even more aggravated by such trials. In addition, if the ongoing trials proved the efficacy of BCG as a prophylaxis against COVID-19, this may open the door to more urological research opportunities to question the possibility that intra-vesical BCG, given its systemic immunologic effect, may have been protective to this subgroup of urological patients. Conclusion: The ongoing clinical trials using BCG against COVID-19 can affect our urology practice. We need to stay vigilant to such impacts: BCG shortage and possible new chances for urology research work.en_US
dc.subjectInfectious Diseasesen_US
dc.subjectMycobacterium bovisen_US
dc.subjectUrinary Bladder Neoplasmsen_US
dc.titleBCG versus COVID-19: impact on urologyen_US
eihealth.categoryClinical characterization and managementen_US
eihealth.categoryCandidate vaccines RDen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalWorld Journal of Urologyen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record